News | July 29, 2009

Patient Advocacy Groups Press Congress to Reject Imaging Reimbursement Cuts

July 30, 2009 - Patients and leading patient advocates from across the country, in partnership with the Medical Imaging and Technology Alliance (MITA, a division of NEMA), gathered yesterday at the U.S. Capitol to call on Congress to reject proposed deep and arbitrary reimbursement cuts to imaging services that would devastate patient access to life-saving diagnostics, particularly in rural communities throughout America.
 
These groups convened to officially submit a letter from thirteen leading patient advocacy groups to the Senate Finance and House Tri-Committees urging members to adopt legislation that preserves access to diagnostic imaging.
 
The letter says that any “proposal to increase the utilization assumption for certain imaging equipment including CTs and MRIs will result in additional draconian cuts for imaging services. These additional cuts would come at a time when the GAO and other Medicare claims analyses have found that the deep cuts imposed by the Deficit Reduction Act have already significantly reduced Medicare spending on imaging (one analysis revealed that spending on advanced imaging is down 19.2%) and dramatically slowed the growth of advanced imaging services (the same study showed that the volume of these services has grown only 1.9 percent in the last year). Further cuts will undoubtedly reduce seniors’ access to these imaging services that are so important for detection, diagnosis and treatment.”
 
To read the letter in its entirety, go to: www.nema.org/media/upload/Advocate_Patient_Group_Letter-to-Congress.pdf.

Related Content

Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
3-D Reconstruction of Ichthyosaurus Skull

A 3-D reconstruction of the ichthyosaurus skull from a computed tomography (CT) scan. Image courtesy of Nigel Larkin, taken at Royal Veterinary College, London.

News | Computed Tomography (CT) | January 09, 2019
A nearly meter-long skull of a giant fossil marine ichthyosaur found in a farmer's field more than 60 years ago has...
SCCT Releases New Guideline for CT Use During TAVR
News | Computed Tomography (CT) | January 08, 2019
The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
First Arterial and Venous Atlas of the Human Brain Released
News | Neuro Imaging | January 02, 2019
January 2, 2019 — Imagine an atlas containing an image bank of the blood vessels of the...
MRI Effective for Monitoring Liver Fat in Obese Patients
News | Magnetic Resonance Imaging (MRI) | December 28, 2018
Magnetic resonance imaging (MRI) provides a safe, noninvasive way to monitor liver fat levels in people who undergo...
CT Technique Expands Possibilities of Imaging Ancient Remains
News | Computed Tomography (CT) | December 27, 2018
Researchers in Sweden using computed tomography (CT) have successfully imaged the soft tissue of an ancient Egyptian...
FDA Approves Exablate Neuro for Tremor-Dominant Parkinson's Treatment
Technology | Focused Ultrasound Therapy | December 21, 2018
Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of...